Introduction: Diabetes mellitus type 2 is a growing health concern that affects several systems in the body, among which is the phonatory apparatus. Voice may be affected in view of the high prevalence of myopathy and neuropathy in diseased subjects. The authors aimed to answer the following question: does type 2 diabetes have an effect on voice? Methods: The systematic review included search terms such as “speech, voice, larynx, glucose, diabetes, and hyperglycemia.” The search strategy yielded 221 articles, only five of which satisfied the inclusion criteria. Articles were considered for inclusion using the PRISMA method. Analysis included 321 patients with type 2 diabetes mellitus and 171 controls. All studies included were case-control studies except for one study which was an observational cohort. Six parameters were chosen as endpoints for the systematic review and meta-analysis: the presence/absence of voice complaints, fundamental frequency, jitter, shimmer, noise-to-harmonic ratio, and maximum phonation time. Results: There was no significant difference in the prevalence of voice complaints (i.e., hoarseness) between diabetic patients and control groups. There was also no significant difference in any of the acoustic and aerodynamic measures between patients with type 2 diabetes and controls. These findings can be ascribed to the high resilience of the laryngeal muscles to the adverse effect of systemic diseases. Conclusion: There is no consensus in the literature that the prevalence of voice symptoms in diabetic patients is significantly higher than that reported in healthy subjects.

Journal Section:
Systematic Review
Keywords:
Diabetes mellitus type 2, Voice, Dysphonia, Larynx, Acoustic analysis
1.
Federation ID. IDF diabetes atlas. 10th ed. International diabetes federation; 2021.
2.
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018 Feb;14(2):88–98.
https://doi.org/10.1038/nrendo.2017.151
3.
American Diabetes Association. Standards of medical care in diabetes -2010. Diabetes Care. 2010;33(Suppl 1):S11–1.
https://doi.org/10.2337/dc10-S011
4.
Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021 Aug;12(8):1322–5.
https://doi.org/10.1111/jdi.13480
5.
Henning RJ. Type-2 diabetes mellitus and cardiovascular disease. Future Cardiol. 2018 Nov;14(6):491–509.
https://doi.org/10.2217/fca-2018-0045
6.
Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms, and management of diabetic gastroparesis. Clin Gastroenterol Hepatol. 2011 Jan;9(1):5–12; quiz e7.
https://doi.org/10.1016/j.cgh.2010.09.022
7.
Qi C, Mao X, Zhang Z, Wu H. Classification and differential diagnosis of diabetic nephropathy. J Diabetes Res. 2017 Oct;2017:8637138.
https://doi.org/10.1155/2017/8637138
8.
Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UK. Diabetes Care. 2011 Oct;34(10):2220–4.
https://doi.org/10.2337/dc11-1108
9.
Jamali R, Mohseni S. Hypoglycaemia causes degeneration of large myelinated nerve fibres in the vagus nerve of insulin-treated diabetic BB/Wor rats. Acta Neuropathol. 2005 Feb;109(2):198–206.
https://doi.org/10.1007/s00401-004-0932-1
10.
Kh SB, Artikova DM, Kh YN, Urunbaeva DA. Features of lung damage in type 2 diabetes. Editor coordinator. 2021:492.
11.
Hamdan AL, Kurban Z, Azar ST. Prevalence of phonatory symptoms in patients with type 2 diabetes mellitus. Acta Diabetol. 2013 Oct;50(5):731–6.
https://doi.org/10.1007/s00592-012-0392-3
12.
Zakaria DA, Bekhet MM, Khodeir MS, Bassiouny SS, Saleh MM. Oropharyngeal dysphagia and diabetes mellitus: screening of 200 type 1 and type 2 patients in Cairo, Egypt. Folia Phoniatr Logop. 2018 Oct;70(3–4):134–7.
https://doi.org/10.1159/000491079
13.
Cohen Atsmoni S, Brener A, Roth Y. Diabetes in the practice of otolaryngology. Diabetes Metab Syndr. 2019 Mar;13(2):1141–50.
https://doi.org/10.1016/j.dsx.2019.01.006
14.
Hamdan AL, Jabbour J, Barazi R, Korban Z, Azar ST. Prevalence of laryngopharyngeal reflux disease in patients with diabetes mellitus. J Voice. 2013 Jul;27(4):495–9.
https://doi.org/10.1016/j.jvoice.2012.07.010
15.
Rosen CA, Lee AS, Osborne J, Zullo T, Murry T. Development and validation of the voice handicap index‐10. Laryngoscope. 2004 Sep;114(9):1549–56.
https://doi.org/10.1097/00005537-200409000-00009
16.
Hirano M. GRBAS scale for evaluating the hoarse voice & frequency range of phonation. Clin examination voice. 1981;5:83–4.
17.
Hamdan AL, Jabbour J, Nassar J, Dahouk I, Azar ST. Vocal characteristics in patients with type 2 diabetes mellitus. Eur Arch Oto-Rhino-Laryngol. 2012 May;269(5):1489–95.
https://doi.org/10.1007/s00405-012-1933-7
18.
Pinyopodjanard S, Suppakitjanusant P, Lomprew P, Kasemkosin N, Chailurkit L, Ongphiphadhanakul B. Instrumental acoustic voice characteristics in adults with type 2 diabetes. J Voice. 2021 Jan;35(1):116–21.
https://doi.org/10.1016/j.jvoice.2019.07.003
19.
Gölaç H, Atalik G, Türkcan AK, Yilmaz M. Disease related changes in vocal parameters of patients with type 2 diabetes mellitus. Logoped Phoniatr Vocol. 2022 Jul;47(3):202–8.
https://doi.org/10.1080/14015439.2021.1917653
20.
Wang X, Pitchumoni CS, Chandrarana K, Shah N. Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy. World J Gastroenterol. 2008 Feb;14(5):709–12.
https://doi.org/10.3748/wjg.14.709
21.
Bainbridge KE, Roy N, Losonczy KG, Hoffman HJ, Cohen SM. Voice disorders and associated risk markers among young adults in the United States. Laryngoscope. 2017 Sep;127(9):2093–9.
https://doi.org/10.1002/lary.26465
22.
Gölaç H, Atalık G, Kemaloğlu YK, Yılmaz M. Reflux, dysphonia, and dysphagia symptoms in patients with diabetes and their association with diabetic complications. Turk J Med Sci. 2022 Jun;52(3):770–7.
https://doi.org/10.55730/1300-0144.5372
23.
Chitkara D, Sharma RK. Voice based detection of type 2 diabetes mellitus. In: 2nd international conference on advances in electrical, electronics, information, communication and bio-informatics (AEEICB) 2016. IEEE; 2016. p. 83–7.
24.
Teixeira JP, Oliveira C, Lopes C. Vocal acoustic analysis–jitter, shimmer and hnr parameters. Proced Technology. 2013 Jan;9:1112–22.
https://doi.org/10.1016/j.protcy.2013.12.124
25.
Román-Pintos LM, Villegas-Rivera G, Rodríguez-Carrizalez AD, Miranda-Díaz AG, Cardona-Muñoz EG. Diabetic polyneuropathy in type 2 diabetes mellitus: inflammation, oxidative stress, and mitochondrial function. J Diabetes Res. 2016;2016:3425617.
https://doi.org/10.1155/2016/3425617
26.
Artkoski M, Tommila J, Laukkanen AM. Changes in voice during a day in normal voices without vocal loading. Logoped Phoniatr Vocol. 2002;27(3):118–23.
https://doi.org/10.1080/140154302760834840
27.
Garrett KL, Healey EC. An acoustic analysis of fluctuations in the voices of normal adult speakers across three times of day. J Acoust Soc Am. 1987;82(1):58–62.
https://doi.org/10.1121/1.395437
28.
Brandon CA, Rosen C, Georgelis G, Horton MJ, Mooney MP, Sciote JJ. Muscle fiber type composition and effects of vocal fold immobilization on the two compartments of the human posterior cricoarytenoid: a case study of four patients. J Voice. 2003;17(1):63–75.
https://doi.org/10.1016/s0892-1997(03)00027-4
29.
Wu YZ, Crumley RL, Armstrong WB, Caiozzo VJ. New perspectives about human laryngeal muscle: single-fiber analyses and interspecies comparisons. Arch Otolaryngol Head Neck Surg. 2000;126(7):857–64.
https://doi.org/10.1001/archotol.126.7.857
30.
Schiaffino S, Reggiani C. Fiber types in mammalian skeletal muscles. Physiol Rev. 2011;91(4):1447–531.
https://doi.org/10.1152/physrev.00031.2010
31.
Ibebunjo C, Srikant CB, Donati F. Properties of fibres, endplates and acetylcholine receptors in the diaphragm, masseter, laryngeal, abdominal and limb muscles in the goat. Can J Anaesth. 1996 May;43(5 Pt 1):475–84.
https://doi.org/10.1007/BF03018110
© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.